Compare ADMA Biologics Inc (ADMA) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs DENTSPLY SIRONA Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: ADMA Biologics Inc and DENTSPLY SIRONA Inc are close in size by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | XRAY | |
|---|---|---|
Market Cap | $2.22B | $2.31B |
Sector | Health | Health |
52-Week High | $20.38 | $14.68 |
52-Week Low | $7.60 | $9.64 |
Enterprise Value | $2.29B | $4.39B |
Dividend Yield | — | 5.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
